315 related articles for article (PubMed ID: 19096157)
1. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.
Colton CA; Wilcock DM; Wink DA; Davis J; Van Nostrand WE; Vitek MP
J Alzheimers Dis; 2008 Dec; 15(4):571-87. PubMed ID: 19096157
[TBL] [Abstract][Full Text] [Related]
2. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.
Wilcock DM; Gharkholonarehe N; Van Nostrand WE; Davis J; Vitek MP; Colton CA
J Neurosci; 2009 Jun; 29(25):7957-65. PubMed ID: 19553436
[TBL] [Abstract][Full Text] [Related]
3. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.
Wilcock DM; Lewis MR; Van Nostrand WE; Davis J; Previti ML; Gharkholonarehe N; Vitek MP; Colton CA
J Neurosci; 2008 Feb; 28(7):1537-45. PubMed ID: 18272675
[TBL] [Abstract][Full Text] [Related]
4. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.
Lüth HJ; Holzer M; Gärtner U; Staufenbiel M; Arendt T
Brain Res; 2001 Sep; 913(1):57-67. PubMed ID: 11532247
[TBL] [Abstract][Full Text] [Related]
5. mNos2 deletion and human NOS2 replacement in Alzheimer disease models.
Colton CA; Wilson JG; Everhart A; Wilcock DM; Puoliväli J; Heikkinen T; Oksman J; Jääskeläinen O; Lehtimäki K; Laitinen T; Vartiainen N; Vitek MP
J Neuropathol Exp Neurol; 2014 Aug; 73(8):752-69. PubMed ID: 25003233
[TBL] [Abstract][Full Text] [Related]
6. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
8. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.
Colton CA; Vitek MP; Wink DA; Xu Q; Cantillana V; Previti ML; Van Nostrand WE; Weinberg JB; Dawson H
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12867-72. PubMed ID: 16908860
[TBL] [Abstract][Full Text] [Related]
9. Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype.
Sudduth TL; Wilson JG; Everhart A; Colton CA; Wilcock DM
PLoS One; 2012; 7(2):e31993. PubMed ID: 22347510
[TBL] [Abstract][Full Text] [Related]
10. Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.
Wilcock DM; Zhao Q; Morgan D; Gordon MN; Everhart A; Wilson JG; Lee JE; Colton CA
ASN Neuro; 2011 Nov; 3(5):249-58. PubMed ID: 21995345
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
12. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
[TBL] [Abstract][Full Text] [Related]
14. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion.
Pagnon de la Vega M; Syvänen S; Giedraitis V; Hooley M; Konstantinidis E; Meier SR; Rokka J; Eriksson J; Aguilar X; Spires-Jones TL; Lannfelt L; Nilsson LNG; Erlandsson A; Hultqvist G; Ingelsson M; Sehlin D
Acta Neuropathol Commun; 2024 Feb; 12(1):22. PubMed ID: 38317196
[TBL] [Abstract][Full Text] [Related]
15. An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
Esquerda-Canals G; Martí-Clúa J; Roda AR; Villegas S
J Alzheimers Dis; 2017; 59(3):1079-1096. PubMed ID: 28697564
[TBL] [Abstract][Full Text] [Related]
16. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
[TBL] [Abstract][Full Text] [Related]
17. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
20. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
Wan J; Fu AK; Ip FC; Ng HK; Hugon J; Page G; Wang JH; Lai KO; Wu Z; Ip NY
J Neurosci; 2010 May; 30(20):6873-81. PubMed ID: 20484629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
